Literature DB >> 25160591

TRIM28/KAP1 regulates senescence.

Joana Santos1, Jesús Gil2.   

Abstract

Senescence is a highly stable cell cycle arrest which limits the replication of cells with damaged genomes. The senescence program is activated during aging or in response to insults like DNA damage or oncogenic signaling. Upon induction of senescence, cells undergo profound changes on their transcription program, chromatin organization, and they secrete a complex mixture of mainly pro-inflammatory components termed the senescence-associated secretory phenotype (SASP). The SASP mediates multiple effects, including reinforcing senescence and activating immune surveillance responses. Given the important role that senescence has in aging, cancer and other pathologies, identifying mechanisms regulating senescence has therapeutic potential. Here we describe a role for TRIM28 (also known as KRAB-associated protein 1, KAP1) on mediating oncogene-induced senescence (OIS). TRIM28 accumulates during OIS becoming phosphorylated on serine 824. To investigate the role of TRIM28, we knocked down its expression and observed that the depletion of TRIM28 partially prevented cell arrest during OIS. While induction of p53 and p21 during OIS, was not affected by TRIM28 depletion, p16(INK4a) induction was partially prevented. Finally, we observed that the induction of IL8, IL6 and other SASP components were strongly suppressed upon TRIM28 depletion. In conclusion, the above-described results show that TRIM28 regulates senescence and affects the induction of the senescence-associated secretory phenotype.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  SASP; Senescence; TRIM28; p16

Mesh:

Substances:

Year:  2014        PMID: 25160591     DOI: 10.1016/j.imlet.2014.08.011

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  TRIM28 as an independent prognostic marker plays critical roles in glioma progression.

Authors:  Zeng-Xin Qi; Jia-Jun Cai; Ling-Chao Chen; Qi Yue; Yan Gong; Yu Yao; Ying Mao
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

Review 2.  TRIM28 as a novel transcriptional elongation factor.

Authors:  Heeyoun Bunch; Stuart K Calderwood
Journal:  BMC Mol Biol       Date:  2015-08-21       Impact factor: 2.946

3.  miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.

Authors:  Zengxin Qi; Shengyong Cai; Jiajun Cai; Lingchao Chen; Yu Yao; Liang Chen; Ying Mao
Journal:  BMC Neurol       Date:  2016-12-01       Impact factor: 2.474

4.  Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.

Authors:  Seán Fitzgerald; Virginia Espina; Lance Liotta; Katherine M Sheehan; Anthony O'Grady; Robert Cummins; Richard O'Kennedy; Elaine W Kay; Gregor S Kijanka
Journal:  J Transl Med       Date:  2018-04-10       Impact factor: 5.531

5.  Merkel Cell Polyomavirus DNA Replication Induces Senescence in Human Dermal Fibroblasts in a Kap1/Trim28-Dependent Manner.

Authors:  Svenja Siebels; Manja Czech-Sioli; Michael Spohn; Claudia Schmidt; Juliane Theiss; Daniela Indenbirken; Thomas Günther; Adam Grundhoff; Nicole Fischer
Journal:  mBio       Date:  2020-03-10       Impact factor: 7.867

6.  TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma.

Authors:  Jie Liu; Xiao Han; Lijuan Chen; Dong Han; Xiaoqian Mu; Xiufeng Hu; Hongbo Wu; Huijuan Wu; Wenjing Liu; Yanqiu Zhao
Journal:  Aging (Albany NY)       Date:  2020-10-22       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.